Synonyms: ABT-493 | ABT493 | Maviret® | Mavyret® (glecaprevir + pibrentasvir)
glecaprevir is an approved drug (EMA & FDA (2017))
Compound class:
Synthetic organic
Comment: Glecaprevir is an orally available anti-hepatitis C virus (HCV) drug. It is a direct-acting inhibitor of the HCV NS3/4A protease, and thereby targets viral RNA replication.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (EMA & FDA (2017)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names | |
INN number | INN |
10261 | glecaprevir |
Synonyms |
ABT-493 | ABT493 | Maviret® | Mavyret® (glecaprevir + pibrentasvir) |
Database Links | |
CAS Registry No. | 1365970-03-1 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL3545363 |
DrugBank Ligand | DB13879 |
DrugCentral Ligand | 5243 |
GtoPdb PubChem SID | 434321702 |
PubChem CID | 66828839 |
RCSB PDB Ligand | O31 |
Search Google for chemical match using the InChIKey | MLSQGNCUYAMAHD-ITNVBOSISA-N |
Search Google for chemicals with the same backbone | MLSQGNCUYAMAHD |
Search PubMed clinical trials | glecaprevir |
Search PubMed titles | glecaprevir |
Search PubMed titles/abstracts | glecaprevir |
UniChem Compound Search for chemical match using the InChIKey | MLSQGNCUYAMAHD-ITNVBOSISA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MLSQGNCUYAMAHD-ITNVBOSISA-N |